Jazz Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
CEOBruce C. Cozadd
CEOBruce C. Cozadd
Employees2,800
Employees2,800
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2005
Founded2005
Employees2,800
Employees2,800
JAZZ Key Statistics
Market cap6.71B
Market cap6.71B
Price-Earnings ratio14.76
Price-Earnings ratio14.76
Dividend yield—
Dividend yield—
Average volume842.08K
Average volume842.08K
High today—
High today—
Low today—
Low today—
Open price$109.89
Open price$109.89
Volume0.00
Volume0.00
52 Week high$148.06
52 Week high$148.06
52 Week low$95.49
52 Week low$95.49
JAZZ News
Seeking Alpha 4d
Jazz Pharmaceuticals succeeds in late-stage study of lung cancer treatmentJazz Pharmaceuticals (NASDAQ:JAZZ) said on Monday that the company's late-stage study of Zepzelca in combination with atezolizumab in small cell lung cancer tre...
Analyst ratings
95%
of 19 ratingsBuy
94.7%
Hold
5.3%
Sell
0%
People also own
Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.